Sebastian Boeltz

Erlangen, BY, Germany

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 38 publications

Syphilis mimicking a metastatic tumour: a case report and review of the literature.

Syphilis mimicking a metastatic tumour: a case report and review of the literature.

Journal: Infection
Published: January 29, 2026

Virus-Specific T Cells and Response to Checkpoint Inhibitors in Progressive Multifocal Leukoencephalopathy.

Virus-Specific T Cells and Response to Checkpoint Inhibitors in Progressive Multifocal Leukoencephalopathy.

Journal: JAMA neurology
Published: January 20, 2026

Low-dose blinatumomab in multidrug-resistant rheumatoid arthritis-a case series.

Low-dose blinatumomab in multidrug-resistant rheumatoid arthritis-a case series.

Journal: Annals of the rheumatic diseases
Published: December 19, 2025

BCMA T-Cell Engager Therapy in Patients with Refractory Autoimmune Disease.

BCMA T-Cell Engager Therapy in Patients with Refractory Autoimmune Disease.

Journal: The New England journal of medicine
Published: October 15, 2025

CD19 CAR-T cells for treatment-refractory autoimmune diseases: the phase 1/2 CASTLE basket trial.

CD19 CAR-T cells for treatment-refractory autoimmune diseases: the phase 1/2 CASTLE basket trial.

Journal: Nature medicine
Published: September 30, 2025

Long-term follow up of efficiency and safety of CD19-CAR T-cell treatment of systemic lupus erythematosus

Long-term follow up of efficiency and safety of CD19-CAR T-cell treatment of systemic lupus erythematosus

Journal: Zeitschrift fur Rheumatologie
Published: July 18, 2025

Deep phenotyping of skin tissue remodeling in patients with systemic sclerosis treated with CD19-CAR T cells.

Deep phenotyping of skin tissue remodeling in patients with systemic sclerosis treated with CD19-CAR T cells.

Journal: Nature communications
Published: July 17, 2025

Management of systemic lupus erythematosus-Including secondary antiphospholipid syndrome, fertility and pregnancy : S3 guidelines of the German Society for Rheumatology and Clinical Immunology and the German Society for Neurology (DGN), German Society for Internal Medicine (DGIM), German Cardiac Society (DGK), Society for Thrombosis and Hemostasis Research (GTH), German Society for Hematology and Medical Oncology (DGHO), German Society for Pediatric and Adolescent Medicine (DGKJ), Society for Pediatric and Adolescent Rheumatology (GKJR), German Society for Nephrology (DGfN), German Society for Pneumology and Ventilation Medicine (DGP), German Rheumatism League National Association, Lupus Erythematosus Self-help Community, German Dermatological Society (DDG). Version: 1.2

Management of systemic lupus erythematosus-Including secondary antiphospholipid syndrome, fertility and pregnancy : S3 guidelines of the German Society for Rheumatology and Clinical Immunology and the German Society for Neurology (DGN), German Society for Internal Medicine (DGIM), German Cardiac Society (DGK), Society for Thrombosis and Hemostasis Research (GTH), German Society for Hematology and Medical Oncology (DGHO), German Society for Pediatric and Adolescent Medicine (DGKJ), Society for Pediatric and Adolescent Rheumatology (GKJR), German Society for Nephrology (DGfN), German Society for Pneumology and Ventilation Medicine (DGP), German Rheumatism League National Association, Lupus Erythematosus Self-help Community, German Dermatological Society (DDG). Version: 1.2

Journal: Zeitschrift fur Rheumatologie
Published: July 07, 2025

Effects of different B-cell-depleting strategies on the lymphatic tissue.

Effects of different B-cell-depleting strategies on the lymphatic tissue.

Journal: Annals of the rheumatic diseases
Published: March 25, 2025

Increased Sensitivity to Ionizing Radiation in a Relevant Subset of Patients with Cancer and Systemic Lupus Erythematosus.

Increased Sensitivity to Ionizing Radiation in a Relevant Subset of Patients with Cancer and Systemic Lupus Erythematosus.

Journal: Cells
Published: March 10, 2025

BCMA CAR T cells in a patient with relapsing idiopathic inflammatory myositis after initial and repeat therapy with CD19 CAR T cells.

BCMA CAR T cells in a patient with relapsing idiopathic inflammatory myositis after initial and repeat therapy with CD19 CAR T cells.

Journal: Nature medicine
Published: January 11, 2025

BCMA-Targeted T-Cell-Engager Therapy for Autoimmune Disease.

BCMA-Targeted T-Cell-Engager Therapy for Autoimmune Disease.

Journal: The New England journal of medicine
Published: September 04, 2024
Showing 1-12 of 38

Last Updated: 09/26/2026